Field watch: Suppressor tRNA therapy rescues nonsense mutations

Chen et al. report in Science a nonviral strategy for treating cystic fibrosis caused by nonsense mutations. The team engineered suppressor tRNAs and delivered them to the lung using inhaled lipid nanoparticles. In CF bronchial cells, mouse models, and patient-derived organoids, the treatment enabled readthrough of premature stop codons and restored full-length CFTR protein and […]

Read More…

Rapid minigene workflow for functional reclassification of splicing variants in hereditary cancer diagnostics (Contributed by Dr Noemi Calandra)

Genetic testing has transformed the diagnosis of hereditary cancer syndromes, but many DNA variants remain difficult to interpret because their biological effects are unknown. This uncertainty can complicate genetic counselling and clinical management. We developed a rapid functional test to experimentally determine whether suspected variants disrupt RNA splicing, the process by which RNA is edited […]

Read More…

Founder variant in OTOG causing non-syndromic sensorineural hearing loss in Irish traveller population (Contributed by Dr Aoife Flynn)

Hearing loss is one of the most common sensory conditions and is often caused by changes in our genes. We identified seven Irish Traveller families with the same inherited change in the OTOG gene, which causes mild-to-moderate hearing loss from early childhood. Most children were identified through the newborn hearing screening programme, and importantly, their […]

Read More…

Pan-ethnic preconception screening: evidence from a large-scale programme in a genetically diverse population (Contributed by Rotem Greenberg)

Before pregnancy, genetic carrier screening can identify couples who both carry changes linked to the same inherited disorder, allowing them to estimate the chance of having an affected child. Traditionally, testing was chosen based on a person’s reported ethnic background, on the belief that certain variants occur primarily in specific populations. In this study, we […]

Read More…

BHLHE22 monoallelic and biallelic variants cause a neurodevelopmental disorder with agenesis of the corpus callosum, intellectual disability, abnormal muscle tone and movement abnormalities (Contributed by Dr. Emanuela Argilli)

This study identifies a previously unrecognized genetic disorder caused by changes in the BHLHE22 gene. Clinical and genetic information from 15 affected individuals in 13 families worldwide revealed a shared pattern of developmental and cognitive delay, movement abnormalities, and defects of the corpus callosum, the structure connecting the two halves of the brain. The disorder […]

Read More…

Common Disease Genetics Field Watch: APOE4 Moves From Association Toward Mechanism in Alzheimer’s Disease

A study is shedding light on how APOE genetics may shape Alzheimer’s disease inside the brain. Researchers compared human astrocytes carrying APOE3 and APOE4 in chimeric mouse models. They found that APOE genotype can influence not only astrocyte behavior, but also Alzheimer-related pathology and microglial responses. The results point to a more specific disease mechanism […]

Read More…

CACNA1C variants associated with focal epilepsy and their correlations with arrhythmias and developmental disorders (Contributed by Dr Chuan-Fang Cheng)

CACNA1C is known to be associated with arrhythmias and developmental disorders, while its role in epilepsy has remained unclear. In this study, we focused on CACNA1C mutations in focal epilepsy, one of the most common seizure types. Using trio-based whole-exome sequencing, we identified three de novo CACNA1C mutations in patients with focal epilepsy. Notably, we […]

Read More…

The British Society for Genetic Medicine guidance on managing incidental findings identified during rare disease genomic testing (Contributed by Dr Sian Ellard)

Genomic testing for people affected by rare diseases will occasionally identify a gene variant or other finding that is not related to the reason for testing. This guidance on managing such “incidental findings” has been developed to support the specialist genomics workforce within the national health services in the UK and Ireland. It describes the […]

Read More…

Enrichment of an Ehlers-Danlos-like Phenotype in Women with the FMR1 Premutation: A Pilot Study (Contributed by Dr Emily L Casanova)

Women who carry the FMR1 premutation are known to be at risk for several fragile X-associated conditions, but connective tissue problems have received relatively little attention. In this pilot study, we found that women with the premutation were much more likely than expected to show features resembling hypermobile Ehlers-Danlos syndrome, including joint hypermobility, chronic pain, […]

Read More…

Everolimus for the treatment of neuropsychological deficits in tuberous sclerosis complex: findings from the TRON multicentre randomised controlled trial (Contributed by Dr Julian R Sampson)

Tuberous sclerosis complex is a rare inherited condition that causes a combination of widespread tumours, epilepsy and neuropsychological problems including autism and learning difficulties. Everolimus is an effective drug for treating the tumours and epilepsy. This paper reports a clinical trial of twenty-four weeks of everolimus treatment compared with placebo (an identical appearing pill without […]

Read More…